Differential expression of mGluR5 in human lumbosacral motoneurons

NeuroReport

Volumn 15, Issue 2, 2004, Pages 271-273

  Anneser, Johanna M H ^a   Ince, Paul G ^b   Shaw, Pamela J ^b   Borasio, Gian Domenico ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

ALS; Immunohistochemistry; Metabotropic glutamate receptor; Onuf's nucleus; Ventral horn

Indexed keywords

METABOTROPIC RECEPTOR; METABOTROPIC RECEPTOR 5;

ARTICLE; AUTONOMIC NERVE; CELL NUCLEUS; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUMBOSACRAL PLEXUS; MALE; MOTONEURON; ONUF NUCLEUS; PARASYMPATHETIC NERVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOMATIC CELL; SPECIES COMPARISON; STATISTICAL SIGNIFICANCE;

AMYOTROPHIC LATERAL SCLEROSIS; DISEASE SUSCEPTIBILITY; GLUTAMIC ACID; HUMANS; IMMUNOHISTOCHEMISTRY; LUMBOSACRAL REGION; MALE; MOTOR NEURONS; NEUROTOXINS; PARASYMPATHETIC NERVOUS SYSTEM; PELVIC FLOOR; RECEPTORS, METABOTROPIC GLUTAMATE; SPINAL CORD;

EID: 1542320276     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-200402090-00012     Document Type: Article

References (21)

1. Ludolph AC, Meyer T and Riepe MW. The role of excitotoxicity in ALS -what is the evidence? J Neurol 247(Suppl), 17-116 (2000).
2. Mannen T, Iwata M, Toyokura Y and Nagashima K. Preservation of a certain motoneurone group of the sacral cord in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 47, 642-653 (1977).
3. Schröder HD and Reske-Nielsen E. Preservation of the nucleus X-pelvic floor motosystem in amyotrophic lateral sclerosis. Clin Neuropathol 3, 210-216 (1984).
4. Anneser JM, Borasio GD, Berthele A, Zieglgansberger W and Tolle TR. Differential expression of group I metabotropic glutamate receptors in rat spinal cord somatic and autonomic motoneurons: possible implications for the pathogenesis of amyotrophic lateral sclerosis. Neurobiol Dis 6, 140-147 (1999).
5. Tomiyama M, Kimura T, Maeda T, Tanaka H, Furusawa K, Kurahashi K et al. Expression of metabotropic glutamate receptor mRNAs in the human spinal cord: implications for selective vulnerability of spinal motor neurons in amyotrophic lateral sclerosis. J Neurol Sci 189, 65-69 (2001).
6. Shaw PJ, Williams TL, Slade JY, Eggett CJ and Ince PG. Low expression of GluR2 AMPA receptor subunit protein by human motor neurons. NeuroReport 10, 261-265 (1999).
7. Iwata M, Inoue K and Mannen T. Functional localization in the Onufrowicz nucleus in man. Clin Neuropathol 12, 112-116 (1993).
8. Pullen AH, Tucker D and Martin JE. Morphological and morphometric characterisation of Onuf's nucleus in the spinal cord in man. J Anat 191, 201-213 (1997).
9. Kihira T, Yoshida S, Yoshimasu F, Wakayama I and Yase Y. Involvement of Onuf's nucleus in amyotrophic lateral sclerosis. J Neurol Sci 147, 81-88 (1997).
10. Kihira T, Yoshida S, Uebayashi Y, Yase Y and Yoshimasu F. Involvement of Onuf's nucleus in ALS: demonstration of intraneuronal conglomerate inclusions and Bunina bodies. J Neurol Sci 104, 119-128 (1991).
11. Okamoto K, Hirai S, Ishiguro K, Kawarabayashi T and Takatama M. Light and electron microscopic and immunohistochemical observations of the Onuf's nucleus of amyotrophic lateral sclerosis. Acta Neuropathol (Berl) 81, 610-614 (1991).
12. Pullen AH and Martin JE. Ultrastructural abnormalities with inclusions in Onuf's nucleus in motor neuron disease (amyotrophic lateral sclerosis). Neuropathol Appl Neurobiol 21, 327-340 (1995).
13. Bergmann M, Volpel M and Kuchelmeister K. Onuf's nucleus is frequently involved in motor neuron disease/amyotrophic lateral sclerosis. J Neurol Sci 129, 141-146 (1995).
14. Williams TL, Day NC, Ince PG, Kamboj RK and Shaw PJ. Calcium-permeable alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors: a molecular determinant of selective vulnerability in amyotrophic lateral sclerosis. Ann Neurol 42, 200-207 (1997).
15. Takuma H, Kwak S, Yoshizawa T and Kanazawa I. Reduction of GluR2 RNA editing, a molecular change that increases calcium influx through AMPA receptors, selective in the ventral grey of patients with amyotrophic lateral sclerosis. Ann Neurol 46, 806-815 (1999).
16. Heath PR, Tomkins J, Ince PG and Shaw PJ. Quantitative assesment of AMPA receptor mRNA in human spinal motor neurons isolated by laser capture microdissection. NeuroReport 13, 1753-1757 (2002).
17. Laslo P, Lipski J and Funk GD. Differential expression of group I metabotropic glutamate receptors in motoneurons at low and high risk for degeneration in ALS. Neuroreport 12, 1903-1908 (2001).
18. Alvarez FJ, Villalba RM, Carr PA, Grandes P and Somohano PM. Differential distribution of metabotropic glutamate receptors 1a, 1b, and 5 in the rat spinal cord. J Comp Neurol 422, 464-487 (2000).
19. Nicoletti F, Bruno V, Catania MV, Battaglia G, Copani A, Barbagallo G et al. Group-I metabotropic glutamate receptors: hypotheses to explain their dual role in neurotoxicity and neuroprotection. Neuropharmacology 38, 1477-1484 (1999).
20. Anneser JM, Horstmann S, Weydt P and Borasio GD. Activation of metabotropic glutamate receptors delays apoptosis of chick embryonic motor neurons in vitro. NeuroReport 9, 2039-2043 (1998).
21. Pizzi M, Benarese M, Boroni F, Goffi F, Valerio A and Spano PF. Neuroprotection by metabotropic glutamate receptor agonists on kainate-induced degeneration of motor neurons in spinal cord slices from adult rat. Neuropharmacology 39, 903-910 (2000).